The arcuate nucleus (ARC) is a critical hypothalamic region that plays a vital role in integrating metabolic signals and controlling energy homeostasis, growth, and reproduction[1]. Located in the mediobasal hypothalamus adjacent to the median eminence, the ARC contains diverse neuronal populations that sense circulating hormones and nutrients, making it a key regulator of endocrine function and metabolic balance[2].
The arcuate nucleus has emerged as an important focus in neurodegenerative disease research due to its roles in metabolic regulation, neuroendocrine function, and its connections to brain regions affected in Alzheimer's and Parkinson's diseases[3].
| Taxonomy | ID | Name / Label |
|---|---|---|
| Cell Ontology (CL) | CL:1001135 | arcuate artery cell |
Proopiomelanocortin (POMC) neurons in the ARC produce alpha-melanocyte-stimulating hormone (α-MSH) and cocaine- and amphetamine-regulated transcript (CART), which promote satiety and energy expenditure[4]. These neurons are essential for maintaining energy homeostasis and have been implicated in neurodegenerative processes due to their metabolic regulatory functions.
Neuropeptide Y (NPY) and agouti-related peptide (AgRP) neurons represent the primary orexigenic (appetite-stimulating) population in the ARC[5]. These neurons co-release GABA and are activated during fasting to stimulate food intake. Dysregulation of NPY/AgRP signaling has been associated with metabolic disturbances in neurodegenerative diseases[6].
The ARC contains tyrosine hydroxylase (TH)-positive dopamine neurons that project to various brain regions[7]. These neurons are part of the tuberoinfundibular dopamine (TID) pathway and regulate prolactin secretion. Alterations in ARC dopamine function have been implicated in Parkinson's disease pathophysiology[8].
The ARC serves as the brain's primary metabolic sensor, integrating signals from:
Hormonal Inputs:
Nutrient Signals:
These signals are processed by ARC neurons to modulate feeding behavior, energy expenditure, and hormone secretion[9].
The hypothalamus, including the ARC, shows early pathology in Alzheimer's disease. Key connections include:
The ARC is affected in PD through:
The ARC is central to the hypothalamic-pituitary axis, regulating:
Anterior Pituitary:
Posterior Pituitary:
These neuroendocrine connections explain how hypothalamic dysfunction can affect systemic physiology and potentially influence neurodegenerative processes[12].
ARC dysfunction contributes to:
These conditions are recognized risk factors for neurodegenerative diseases, establishing the ARC as a potential therapeutic target[13].
Modulating ARC neuronal activity represents a potential approach for:
Metabolic intervention in neurodegeneration
Neuroprotective strategies targeting hypothalamic function
Addresses the growing evidence linking metabolic health to brain aging
Schwartz MW, Woods SC, Porte D Jr, et al. Central nervous system control of food intake. 2000. ↩︎
Cone RD, Cowley MA, Butler AA, et al. The arcuate nucleus as a conduit for diverse signals relevant to energy homeostasis. 2001. ↩︎
Saper CB, Fuller PW, Pedersen NP, et al. Sleep state switching. 2010. ↩︎
Yaswen L, Diehl N, Brennan MB, et al. Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. 1999. ↩︎
Krashes MJ, Shah BP, Koda S, et al. Rapid versus delayed stimulation of feeding by the same Arch/NPY neurons. 2013. ↩︎
Luquet S, Perez FA, Hnasko TS, et al. NPY/AgRP neurons are essential for feeding in adult mice but can be ablated in neonates. 2005. ↩︎
Fuxe K, Hökfelt T, et al. Dopamine in the hypothalamus: facts and implications. 2020. ↩︎
Björklund A, Dunnett SB. Dopamine neuron systems in the brain: emerging functional properties. 2007. ↩︎
Morton GJ, Cummings DE, Baskin DG, et al. Central nervous system control of food intake and body weight. 2006. ↩︎
de la Monte SM, Wands JR. Alzheimer's disease is type 3 diabetes-evidence reviewed. 2008. ↩︎
Chaudhuri KR, Healy DG, Schapira AH. Non-motor symptoms of Parkinson's disease: diagnosis and management. 2006. ↩︎
Low VF, Dragich NJ. Neurohypophyseal hormones in brain. 2020. ↩︎
Profenno LA, Porsteinsson AP, Faraone SV. Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and glucose disorders. 2010. ↩︎